Bespoke Extracts (BSPK) Interest Coverage Ratio Growth (1y) (2015 - 2025)
Bespoke Extracts (BSPK) Interest Coverage Ratio Growth (1y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -14.04% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -63.16% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -58.34% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 97.17% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -87.09% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -14.91% |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 | 88.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 88.85% |
| Jun 30, 2025 | 89.86% |
| Mar 31, 2025 | 88.54% |
| Dec 31, 2024 | 98.26% |
| Sep 30, 2024 | -435.12% |
| Jun 30, 2024 | -89.95% |
| Mar 31, 2024 | -379.13% |
| Dec 31, 2023 | -2,871.64% |
| Sep 30, 2023 | 77.70% |
| Jun 30, 2023 | -293.26% |
| Mar 31, 2023 | 56.41% |
| May 31, 2020 | -414.21% |
| Feb 29, 2020 | 52.32% |
| Nov 30, 2019 | -146.76% |
| Aug 31, 2019 | -4,518,133.84% |
| May 31, 2019 | 33.43% |
| Feb 28, 2019 | 88.03% |
| Nov 30, 2018 | 578.56% |
| Aug 31, 2018 | 121.59% |
| May 31, 2018 | 98.46% |